These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20437099)

  • 1. Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi.
    Yu XH; Xu LB; Liu C; Zhang R; Wang J
    Dig Dis Sci; 2011 Jan; 56(1):252-9. PubMed ID: 20437099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi.
    Pang YB; Zhong JH; Luo XL; Ou C; Guo Z; Xiang BD; Peng NF; Li LQ
    Tumour Biol; 2016 May; 37(5):5879-84. PubMed ID: 26586401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.
    Guo Z; Li LQ; Jiang JH; Ou C; Zeng LX; Xiang BD
    World J Gastroenterol; 2014 Feb; 20(8):2098-106. PubMed ID: 24616575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: a matched study.
    Kim JM; Kwon CHD; Joh JW; Sinn DH; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    Medicine (Baltimore); 2015 Feb; 94(6):e450. PubMed ID: 25674733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis.
    Ma YC; Yang JY; Yan LN
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1007-16. PubMed ID: 23478672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus.
    Oba A; Takahashi S; Kato Y; Gotohda N; Kinoshita T; Shibasaki H; Ikeda M; Konishi M
    Anticancer Res; 2014 Aug; 34(8):4367-72. PubMed ID: 25075073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bile duct resection on the prognosis of patients with hepatocellular carcinoma combined with extrahepatic bile duct tumor thrombus.
    Yu X; Liang QZ; Wang JL; Pei YC; Cai JP; Chen LH; Liu Q; Lan T; Chen W; Liang LJ
    BMC Cancer; 2024 Aug; 24(1):969. PubMed ID: 39112950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hepatocellular carcinoma bile duct tumor thrombi in liver transplantation.
    Kim JM; Kwon CH; Joh JW; Park JB; Gwak MS; Lee JH; Kim GS; Kim SJ; Lee SK
    Hepatogastroenterology; 2014 Sep; 61(134):1673-6. PubMed ID: 25436361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
    Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
    Chan AW; Tong JH; Chan SL; Lai PB; To KF
    Histopathology; 2014 Jun; 64(7):935-50. PubMed ID: 24506513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of hepatocellular carcinoma with bile duct tumor thrombus after R0 resection: a matched study.
    Wang DD; Wu LQ; Wang ZS
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):626-632. PubMed ID: 27919852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers.
    Ikeda H; Harada K; Sato Y; Sasaki M; Yoneda N; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Am J Clin Pathol; 2013 Sep; 140(3):329-40. PubMed ID: 23955451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
    Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
    Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice.
    Orimo T; Kamiyama T; Yokoo H; Wakayama K; Shimada S; Tsuruga Y; Kamachi H; Taketomi A
    Ann Surg Oncol; 2016 Aug; 23(8):2627-34. PubMed ID: 27006124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Yu XH; Xu LB; Zeng H; Zhang R; Wang J; Liu C
    Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):620-5. PubMed ID: 22146626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
    Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
    J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stem/progenitor cells in the canals of Hering: cellular origin of hepatocellular carcinoma with bile duct tumor thrombi?
    Peng N; Li L; Cai X; Tan S; Wu T
    Stem Cell Rev Rep; 2010 Dec; 6(4):579-84. PubMed ID: 20809255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
    Yang W; Wang C; Lin Y; Liu Q; Yu LX; Tang L; Yan HX; Fu J; Chen Y; Zhang HL; Tang L; Zheng LY; He YQ; Li YQ; Wu FQ; Zou SS; Li Z; Wu MC; Feng GS; Wang HY
    J Hepatol; 2012 Sep; 57(3):613-20. PubMed ID: 22612999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.